- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/08 - Clostridium, e.g. Clostridium tetani
Patent holdings for IPC class A61K 39/08
Total number of patents in this class: 863
10-year publication summary
|
76
|
46
|
52
|
61
|
67
|
59
|
28
|
27
|
33
|
28
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2337 |
48 |
| Glaxosmithkline Biologicals S.A. | 1650 |
38 |
| Revance Therapeutics, Inc. | 127 |
26 |
| The University of Tokyo | 4200 |
16 |
| MERZ PHARMA GmbH & CO. KGaA | 609 |
15 |
| Wyeth LLC | 657 |
13 |
| University of Guelph | 359 |
13 |
| Valneva Austria GmbH | 115 |
13 |
| The Regents of the University of California | 20059 |
12 |
| Pfizer Inc. | 3368 |
11 |
| Wisconsin Alumni Research Foundation | 3888 |
11 |
| The Trustees of the University of Pennsylvania | 4337 |
10 |
| University of South Florida | 1837 |
8 |
| Sanofi Pasteur Inc. | 362 |
8 |
| Zoetis Services LLC | 1536 |
7 |
| Novartis AG | 10730 |
6 |
| The Regents of the University of Michigan | 4739 |
6 |
| The Board of Regents of the University of Oklahoma | 618 |
6 |
| Inovio Pharmaceuticals, Inc. | 322 |
6 |
| Intervet Inc. | 910 |
6 |
| Other owners | 584 |